Chronic actinic dermatitis: successful treatment with psoralen-ultraviolet A photochemotherapy
Autor: | L. Novakovic, T. Garibaldinos, S.N. Chee, Hiva Fassihi, Robert Sarkany |
---|---|
Rok vydání: | 2018 |
Předmět: |
Adult
Male medicine.medical_specialty Systemic immunosuppression Photodermatosis Dermatology Psoralen ultraviolet a Drug Administration Schedule 030207 dermatology & venereal diseases 03 medical and health sciences 0302 clinical medicine First line therapy medicine Humans Chronic actinic dermatitis Photosensitivity Disorders PUVA Therapy Retrospective Studies Second-line therapy Photosensitizing Agents business.industry medicine.disease 030220 oncology & carcinogenesis 5-Methoxypsoralen Methoxsalen Female business |
Zdroj: | British Journal of Dermatology. 178:e189-e190 |
ISSN: | 0007-0963 |
DOI: | 10.1111/bjd.15969 |
Popis: | Chronic actinic dermatitis (CAD) is a debilitating photodermatosis. First line therapy consists of strict photoprotection and topical corticosteroids. Second line therapy uses systemic immunosuppression. However an alternative is needed for patients with severe CAD who cannot use systemic immunosuppressants.1,2 Case reports and small case series suggest that PUVA may be effective.3-6 This article is protected by copyright. All rights reserved.+ |
Databáze: | OpenAIRE |
Externí odkaz: |